N-linked glycosylation of VWF modulates its interaction with ADAMTS13
Open Access
- 15 March 2008
- journal article
- Published by American Society of Hematology in Blood
- Vol. 111 (6), 3042-3049
- https://doi.org/10.1182/blood-2007-06-095042
Abstract
We examined the role of N-linked glycan structures of VWF on its interaction with ADAMTS13. PNGase F digestion followed by lectin analysis demonstrated that more than 90% of VWF N-linked glycan chains could be removed from the molecule (PNG-VWF) without disruption of its multimeric structure or its ability to bind to collagen. PNG-VWF had an approximately 4-fold increased affinity for ADAMTS13 compared with control VWF. PNG-VWF was cleaved by ADAMTS13 faster than control VWF and was also proteolysed in the absence of urea. Occupancy of the N-linked glycan sites at N1515 and N1574 and their presentation of ABO(H) blood group sugars were confirmed with an isolated tryptic fragment. Recombinant VWF was mutated to prevent glycosylation at these sites. Mutation of N1515 did not alter ADAMTS13 binding or increase rate of ADAMTS13 proteolysis. Mutation of N1574 increased the susceptibility of VWF to ADAMTS13 proteolysis and allowed cleavage in the absence of urea. Mutation of N1574 in the isolated recombinant VWF-A2 domain also increased binding and ADAMTS13 proteolysis. These data demonstrate that the N-linked glycans of VWF have a modulatory effect on the interaction with ADAMTS13. At least part of this effect is conformational, but steric hindrance may also be important.Keywords
This publication has 36 references indexed in Scilit:
- Bombay phenotype is associated with reduced plasma-VWF levels and an increased susceptibility to ADAMTS13 proteolysisBlood, 2005
- A novel mechanism of factor VIII protection by von Willebrand factor from activated protein C–catalyzed inactivationBlood, 2002
- BIOCHEMISTRY AND GENETICS OF VON WILLEBRAND FACTORAnnual Review of Biochemistry, 1998
- Human plasma alpha 2-macroglobulin and von Willebrand factor possess covalently linked ABO(H) blood group antigens in subjects with corresponding ABO phenotypeBlood, 1993
- Cell Biology of von Willebrand FactorAnnual Review of Cell Biology, 1990
- Sialic acid prevents loss of large von Willebrand factor multimers by protecting against amino-terminal proteolytic cleavageBlood, 1988
- The effect of ABO blood group on the diagnosis of von Willebrand diseaseBlood, 1987
- Amino acid sequence of human von Willebrand factorBiochemistry, 1986
- Carbohydrate moiety of von Willebrand factor is not necessary for maintaining multimeric structure and ristocetin cofactor activity but protects from proteolytic degradation.Journal of Clinical Investigation, 1984
- The Plasma Concentration of Factor VIII in the Normal PopulationBritish Journal of Haematology, 1964